Additional targets with pharmacological relevance for AMD are regulators of cholesterol biosynthesis, lipid homeostasis, and metabolism, since drugs that promote lipidic clearance and APOE-mediated cholesterol efflux have shown promising results in vitro and in vivo [9]. Here, APOE is linked to age-related macular degeneration.